It’s the latest indication for New York-based Aidoc’s triage and notification system, which has already been FDA 510(k) cleared for flagging suspected intracranial hemorrhage, large vessel occlusions, acute cervical spine fractures, pulmonary embolism, incidental pulmonary embolism, intra-abdominal free gas and rib fractures.
The new offering runs on all X-ray machines (including portable devices) to automatically flag suspected cases of pneumothorax so radiologists and other doctors can act before respiratory or cardiac failure.
“This FDA clearance further validates the breadth of our AI platform, going beyond specific AI algorithms to act as a healthcare AI hub for the enterprise’s cross-specialty needs,” Aidoc CEO Elad Walach said in a news release. “This includes ER, ICU, outpatient centers, inpatient admissions, and the coordination of care and communication among providers. By bringing radiologists and proceduralists to the same AI platform, we enable enhanced collaboration across departments and systems to deliver patients with the right treatment at the right time.”
Founded in 2016, Aidoc says it has raised more than $140 million and employs more than 240 people.